About POC Hematology Diagnostics
POC hematology diagnostics include hemoglobin, hematocrit (Hct), white blood cells (WBC), and platelet function tests that provide fast and accurate results.
Technavio’s analysts forecast the Global POC Hematology Diagnostics Market to grow at a CAGR of 8.94% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the POC hematology diagnostics market. To calculate the market size, the report considers the revenue generated by sales of POC hematology diagnostics equipment and consumables across the globe.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, POC hematology diagnostics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche
• Siemens Healthcare
• Sysmex
Market driver
• Increase in number of hematology and infectious conditions
• For a full, detailed list, view our report
Market challenge
• High cost of POC hematology diagnostic products
• For a full, detailed list, view our report
Market trend
• Increase in number of OEMs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Consumables – Market size and forecast 2017-2022
• Systems – Market size and forecast 2017-2022
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increase in number of OEMs
• Increase in online marketing
• Increase in adoption of next-generation hematology diagnostic products
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche
• Siemens Healthcare
• Sysmex
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global POC diagnostics market segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global POC hematology diagnostics Market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global POC hematology diagnostics market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global POC hematology diagnostics market by product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global POC hematology diagnostics consumables market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global POC hematology diagnostics consumables market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global POC hematology diagnostics systems market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global POC hematology diagnostics systems market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC hematology diagnostics market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: POC hematology diagnostics market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: POC hematology diagnostics market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: POC hematology diagnostics market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: POC hematology diagnostics market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: POC hematology diagnostics market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: POC hematology diagnostics market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Market impact analysis: Hematology and infectious conditions
Exhibit 39: POC hematology diagnostics: Product launches
Exhibit 40: Increasing number of M&A in the global POC hematology diagnostics market
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott – Overview
Exhibit 47: Abbott – Business segments
Exhibit 48: Abbott – Organizational developments
Exhibit 49: Abbott – Geographic focus
Exhibit 50: Abbott – Segment focus
Exhibit 51: Abbott – Key offerings
Exhibit 52: Abbott – Key customers
Exhibit 53: Danaher – Overview
Exhibit 54: Danaher – Business segments
Exhibit 55: Danaher – Organizational developments
Exhibit 56: Danaher – Geographic focus
Exhibit 57: Danaher – Segment focus
Exhibit 58: Danaher – Key offerings
Exhibit 59: Danaher – Key customers
Exhibit 60: EKF Diagnostics – Overview
Exhibit 61: EKF Diagnostics – Business segments
Exhibit 62: EKF Diagnostics – Organizational developments
Exhibit 63: EKF Diagnostics – Geographic focus
Exhibit 64: EKF Diagnostics – Segment focus
Exhibit 65: EKF Diagnostics – Key offerings
Exhibit 66: EKF Diagnostics – Key customers
Exhibit 67: F. Hoffmann-La Roche – Overview
Exhibit 68: F. Hoffmann-La Roche – Business segments
Exhibit 69: F. Hoffmann-La Roche – Organizational developments
Exhibit 70: F. Hoffmann-La Roche – Geographic focus
Exhibit 71: F. Hoffmann-La Roche – Segment focus
Exhibit 72: F. Hoffmann-La Roche – Key offerings
Exhibit 73: F. Hoffmann-La Roche – Key customers
Exhibit 74: Siemens Healthcare – Overview
Exhibit 75: Siemens Healthcare – Business segments
Exhibit 76: Siemens Healthcare – Organizational developments
Exhibit 77: Siemens Healthcare – Segment focus
Exhibit 78: Siemens Healthcare – Key offerings
Exhibit 79: Siemens Healthcare – Key customers
Exhibit 80: Sysmex – Overview
Exhibit 81: Sysmex – Business segments
Exhibit 82: Sysmex – Organizational developments
Exhibit 83: Sysmex – Geographic focus
Exhibit 84: Sysmex – Segment focus
Exhibit 85: Sysmex – Key offerings
Exhibit 86: Sysmex – Key customers
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Consumables – Market size and forecast 2017-2022
• Systems – Market size and forecast 2017-2022
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increase in number of OEMs
• Increase in online marketing
• Increase in adoption of next-generation hematology diagnostic products
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche
• Siemens Healthcare
• Sysmex
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global POC diagnostics market segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global POC hematology diagnostics Market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global POC hematology diagnostics market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global POC hematology diagnostics market by product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global POC hematology diagnostics consumables market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global POC hematology diagnostics consumables market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global POC hematology diagnostics systems market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global POC hematology diagnostics systems market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC hematology diagnostics market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: POC hematology diagnostics market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: POC hematology diagnostics market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: POC hematology diagnostics market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: POC hematology diagnostics market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: POC hematology diagnostics market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: POC hematology diagnostics market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Market impact analysis: Hematology and infectious conditions
Exhibit 39: POC hematology diagnostics: Product launches
Exhibit 40: Increasing number of M&A in the global POC hematology diagnostics market
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott – Overview
Exhibit 47: Abbott – Business segments
Exhibit 48: Abbott – Organizational developments
Exhibit 49: Abbott – Geographic focus
Exhibit 50: Abbott – Segment focus
Exhibit 51: Abbott – Key offerings
Exhibit 52: Abbott – Key customers
Exhibit 53: Danaher – Overview
Exhibit 54: Danaher – Business segments
Exhibit 55: Danaher – Organizational developments
Exhibit 56: Danaher – Geographic focus
Exhibit 57: Danaher – Segment focus
Exhibit 58: Danaher – Key offerings
Exhibit 59: Danaher – Key customers
Exhibit 60: EKF Diagnostics – Overview
Exhibit 61: EKF Diagnostics – Business segments
Exhibit 62: EKF Diagnostics – Organizational developments
Exhibit 63: EKF Diagnostics – Geographic focus
Exhibit 64: EKF Diagnostics – Segment focus
Exhibit 65: EKF Diagnostics – Key offerings
Exhibit 66: EKF Diagnostics – Key customers
Exhibit 67: F. Hoffmann-La Roche – Overview
Exhibit 68: F. Hoffmann-La Roche – Business segments
Exhibit 69: F. Hoffmann-La Roche – Organizational developments
Exhibit 70: F. Hoffmann-La Roche – Geographic focus
Exhibit 71: F. Hoffmann-La Roche – Segment focus
Exhibit 72: F. Hoffmann-La Roche – Key offerings
Exhibit 73: F. Hoffmann-La Roche – Key customers
Exhibit 74: Siemens Healthcare – Overview
Exhibit 75: Siemens Healthcare – Business segments
Exhibit 76: Siemens Healthcare – Organizational developments
Exhibit 77: Siemens Healthcare – Segment focus
Exhibit 78: Siemens Healthcare – Key offerings
Exhibit 79: Siemens Healthcare – Key customers
Exhibit 80: Sysmex – Overview
Exhibit 81: Sysmex – Business segments
Exhibit 82: Sysmex – Organizational developments
Exhibit 83: Sysmex – Geographic focus
Exhibit 84: Sysmex – Segment focus
Exhibit 85: Sysmex – Key offerings
Exhibit 86: Sysmex – Key customers
